Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sigma Healthcare Ltd ( (AU:SIG) ) has shared an update.
Sigma Healthcare Ltd, a prominent player in the pharmaceutical industry, has released its annual report for 2025, highlighting a new partnership and various operational insights. The report covers key areas such as logistics, sustainability, and financial performance, indicating a strategic focus on strengthening foundations and future growth. This announcement is significant as it outlines Sigma’s commitment to enhancing its market position and delivering value to stakeholders.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.40 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Average Trading Volume: 24,755,814
Technical Sentiment Signal: Buy
Current Market Cap: A$34.45B
For detailed information about SIG stock, go to TipRanks’ Stock Analysis page.

